It underscored the need for additional research on the long-term efficacy of drugs like retatrutide
The Beneficiaries of GLP-1 Drugs Across Industries Health Insurers and the Cost of Obesity Source: McKinsey 4 Although weight loss has been the main focus in the analyses of these drugs so far, it is important to bear in mind that with them comes the improvement in other measurements of health, such as blood glucose levels, cardiovascular parameters, cholesterol and triglyceride levels
28 , S405S406 (2020)
gradual weight loss through diet and exercise may provide modest symptom improvement Smoking cessation : Smoking increases hot flash risk and severity Environmental modifications : Maintaining cool ambient temperatures, using fans, wearing layered clothing, and keeping cold water accessible Stress reduction techniques : While mindfulness meditation, yoga, and paced respiration (slow, deep breathing) are commonly recommended, evidence for their effectiveness in reducing vasomotor symptoms is limited or inconsistent When lifestyle measures prove insufficient, pharmacological intervention becomes appropriate
The pharmaceutical industry is developing newer and potentially cheaper or more effective molecules that target GLP-1 and associated pathways (for example, the so-called dual- and triple-agonists tirzepatide, retatutride and orfoglipon) 257,258
Test typical queries: limit changes, bonus clarification, and document verification
.png)
